Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Kinetics and biological characteristics of humoral response developing after SARS-CoV-2 infection: implications for vaccination ; volume:59 ; number:8 ; year:2021 ; pages:1333-1335 ; extent:03
Clinical chemistry and laboratory medicine ; 59, Heft 8 (2021), 1333-1335 (gesamt 03)
- Creator
- DOI
-
10.1515/cclm-2021-0038
- URN
-
urn:nbn:de:101:1-2022053114414003792474
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lippi, Giuseppe
- Sciacovelli, Laura
- Trenti, Tommaso
- Plebani, Mario
Other Objects (12)
Clinical Chemistry Laboratory Medicine in the post-acute COVID-19 era
SARS-CoV-2 is here to stay: do not lower our guard
Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands
Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
Clinical Chemistry and Laboratory Medicine continues to shine brightly in the constellation of laboratory medicine
Diabetes alert dogs: a narrative critical overview
Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays
An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs)
Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
Clinical Chemistry Laboratory Medicine in the post-acute COVID-19 era
SARS-CoV-2 is here to stay: do not lower our guard
Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands
Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
Clinical Chemistry and Laboratory Medicine continues to shine brightly in the constellation of laboratory medicine
Diabetes alert dogs: a narrative critical overview
Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays
An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs)
Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants
Potential preanalytical and analytical vulnerabilities in the laboratory diagnosis of coronavirus disease 2019 (COVID-19)
Clinical Chemistry Laboratory Medicine in the post-acute COVID-19 era
SARS-CoV-2 is here to stay: do not lower our guard
Standardization and harmonization in laboratory medicine: not only for clinical chemistry measurands
Clinical Chemistry and Laboratory Medicine: enjoying the present and assessing the future
Cytokine “storm”, cytokine “breeze”, or both in COVID-19?
Clinical Chemistry and Laboratory Medicine continues to shine brightly in the constellation of laboratory medicine
Diabetes alert dogs: a narrative critical overview
Optimizing effectiveness of COVID-19 vaccination: will laboratory stewardship play a role?
Pooled analysis of laboratory-based SARS-CoV-2 antigen immunoassays
An overview of the most important preanalytical factors influencing the clinical performance of SARS-CoV-2 antigen rapid diagnostic tests (Ag-RDTs)
Commercial immunoassays for detection of anti-SARS-CoV-2 spike and RBD antibodies: urgent call for validation against new and highly mutated variants